magnesium sulfate has been researched along with Atherosclerotic Parkinsonism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| al Deeb, SM; al Moutaery, K; Khan, HA; Tariq, M | 1 |
| Brundin, P; Clarke, DJ; Karlsson, J; Love, RM | 1 |
2 other study(ies) available for magnesium sulfate and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Effect of chronic administration of magnesium sulfate on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anticonvulsants; Dopamine; Dopamine Agents; Drug Interactions; Female; Magnesium Sulfate; Mice; Mice, Inbred C57BL; Motor Activity; Nervous System; Parkinson Disease, Secondary | 1998 |
Effects of anaesthetics and lazaroid U-83836E on survival of transplanted rat dopaminergic neurones.
Topics: Anesthetics, Combined; Anesthetics, Inhalation; Animals; Antioxidants; Behavior, Animal; Brain Tissue Transplantation; Cell Survival; Chloral Hydrate; Chromans; Dopamine; Female; Fetal Tissue Transplantation; Graft Survival; Isoflurane; Lipid Peroxidation; Magnesium Sulfate; Neurons; Oxidative Stress; Parkinson Disease, Secondary; Pentobarbital; Piperazines; Pregnancy; Rats; Rats, Sprague-Dawley | 1999 |